Efthymios Manolis

1.2k total citations
18 papers, 595 citations indexed

About

Efthymios Manolis is a scholar working on Statistics and Probability, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Efthymios Manolis has authored 18 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Statistics and Probability, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Economics and Econometrics. Recurrent topics in Efthymios Manolis's work include Statistical Methods in Clinical Trials (10 papers), Pharmaceutical studies and practices (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Efthymios Manolis is often cited by papers focused on Statistical Methods in Clinical Trials (10 papers), Pharmaceutical studies and practices (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Efthymios Manolis collaborates with scholars based in Netherlands, Sweden and Belgium. Efthymios Manolis's co-authors include Gérard Pons, Spiros Vamvakas, Sandra A. G. Visser, Marco Cavaleri, Kristin Karlsson, Kevin Dykstra, Scott Marshall, Flora T. Musuamba, Kevin Krudys and Rajanikanth Madabushi and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Kidney Diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

Efthymios Manolis

18 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Efthymios Manolis Netherlands 12 163 115 110 93 90 18 595
Janet R. Wade United States 19 200 1.2× 193 1.7× 116 1.1× 105 1.1× 112 1.2× 37 1.0k
Jakob Ribbing Sweden 10 141 0.9× 149 1.3× 126 1.1× 95 1.0× 174 1.9× 21 1.0k
Helen Kastrissios United States 19 162 1.0× 104 0.9× 114 1.0× 65 0.7× 164 1.8× 49 1.4k
Christian Laveille France 14 176 1.1× 150 1.3× 120 1.1× 102 1.1× 202 2.2× 33 1.0k
Justin Earp United States 17 146 0.9× 124 1.1× 231 2.1× 156 1.7× 80 0.9× 36 829
Chandrahas Sahajwalla United States 14 169 1.0× 75 0.7× 151 1.4× 100 1.1× 118 1.3× 44 771
MO Karlsson Sweden 17 192 1.2× 148 1.3× 203 1.8× 156 1.7× 242 2.7× 29 1.2k
Kevin Krudys United States 11 192 1.2× 116 1.0× 202 1.8× 92 1.0× 100 1.1× 20 792
Nancy Yuen United States 7 50 0.3× 83 0.7× 44 0.4× 133 1.4× 104 1.2× 9 534
Sam Haidar United States 14 274 1.7× 265 2.3× 135 1.2× 104 1.1× 54 0.6× 21 972

Countries citing papers authored by Efthymios Manolis

Since Specialization
Citations

This map shows the geographic impact of Efthymios Manolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efthymios Manolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efthymios Manolis more than expected).

Fields of papers citing papers by Efthymios Manolis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efthymios Manolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efthymios Manolis. The network helps show where Efthymios Manolis may publish in the future.

Co-authorship network of co-authors of Efthymios Manolis

This figure shows the co-authorship network connecting the top 25 collaborators of Efthymios Manolis. A scholar is included among the top collaborators of Efthymios Manolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efthymios Manolis. Efthymios Manolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Colin, Pieter, et al.. (2025). Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA. Clinical Pharmacology & Therapeutics. 117(3). 808–817. 4 indexed citations
2.
Manolis, Efthymios, et al.. (2024). EMA perspective on the value of model‐informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1820–1823. 5 indexed citations
3.
Manolis, Efthymios, Alfredo García‐Arieta, Anders Lindahl, et al.. (2023). Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective. CPT Pharmacometrics & Systems Pharmacology. 12(5). 556–559. 12 indexed citations
4.
Manolis, Efthymios, Flora T. Musuamba, & Kristin Karlsson. (2021). The European Medicines Agency Experience With Pediatric Dose Selection. The Journal of Clinical Pharmacology. 61(S1). S22–S27. 8 indexed citations
5.
Musuamba, Flora T., R Lesage, Giulia Russo, et al.. (2021). Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility. CPT Pharmacometrics & Systems Pharmacology. 10(8). 804–825. 85 indexed citations
6.
Musuamba, Flora T., Roberta Bursi, Efthymios Manolis, et al.. (2020). Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges. CPT Pharmacometrics & Systems Pharmacology. 9(4). 195–197. 19 indexed citations
7.
Manolis, Efthymios, Flora T. Musuamba, & Kristin Karlsson. (2020). Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030. Clinical Pharmacology & Therapeutics. 107(4). 746–748. 2 indexed citations
8.
Thomson, Andrew, Efthymios Manolis, Kevin Blake, et al.. (2019). Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics. British Journal of Clinical Pharmacology. 85(4). 659–668. 33 indexed citations
9.
Marshall, Scott, Rajanikanth Madabushi, Efthymios Manolis, et al.. (2018). Model‐Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives. CPT Pharmacometrics & Systems Pharmacology. 8(2). 87–96. 84 indexed citations
10.
Ehmann, Falk, et al.. (2015). Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union. Expert Opinion on Pharmacotherapy. 16(6). 903–911. 6 indexed citations
11.
Cavaleri, Marco & Efthymios Manolis. (2015). Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience. Clinical Infectious Diseases. 61(suppl 1). S1–S4. 30 indexed citations
12.
Manolis, Efthymios, Armin Koch, Dieter Deforce, & Spiros Vamvakas. (2014). The European Medicines Agency Experience with Biomarker Qualification. Methods in molecular biology. 1243. 255–272. 10 indexed citations
13.
Visser, Sandra A. G., Efthymios Manolis, Meindert Danhof, & Thomas Kerbusch. (2013). Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development. CPT Pharmacometrics & Systems Pharmacology. 2(2). 1–3. 12 indexed citations
14.
Manolis, Efthymios, et al.. (2013). The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop. CPT Pharmacometrics & Systems Pharmacology. 2(2). 1–4. 44 indexed citations
15.
Manolis, Efthymios, Ralf Herold, Franz Koenig, et al.. (2011). Role of modeling and simulation in pediatric investigation plans. Pediatric Anesthesia. 21(3). 214–221. 62 indexed citations
16.
Manolis, Efthymios, Spiros Vamvakas, & Maria Isaac. (2011). New pathway for qualification of novel methodologies in the European medicines agency. PROTEOMICS - CLINICAL APPLICATIONS. 5(5-6). 248–255. 30 indexed citations
17.
Manolis, Efthymios & Gérard Pons. (2009). Proposals for model‐based paediatric medicinal development within the current European Union regulatory framework. British Journal of Clinical Pharmacology. 68(4). 493–501. 85 indexed citations
18.
Kamar, Nassim, Étienne Chatelut, Efthymios Manolis, et al.. (2004). Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. American Journal of Kidney Diseases. 43(1). 140–146. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet R. Wade Breakdown of academic impact, for papers by Jakob Ribbing Breakdown of academic impact, for papers by Helen Kastrissios Breakdown of academic impact, for papers by Christian Laveille Breakdown of academic impact, for papers by Justin Earp Breakdown of academic impact, for papers by Chandrahas Sahajwalla Breakdown of academic impact, for papers by MO Karlsson Breakdown of academic impact, for papers by Kevin Krudys Breakdown of academic impact, for papers by Nancy Yuen Breakdown of academic impact, for papers by Sam Haidar
Rankless by CCL
2026